[go: up one dir, main page]

AR037046A1 - Un procedimiento para la preparacion de tetralona racemica opticamente pura o enriquecida - Google Patents

Un procedimiento para la preparacion de tetralona racemica opticamente pura o enriquecida

Info

Publication number
AR037046A1
AR037046A1 ARP020104076A ARP020104076A AR037046A1 AR 037046 A1 AR037046 A1 AR 037046A1 AR P020104076 A ARP020104076 A AR P020104076A AR P020104076 A ARP020104076 A AR P020104076A AR 037046 A1 AR037046 A1 AR 037046A1
Authority
AR
Argentina
Prior art keywords
tetralone
optically pure
procedure
preparation
racemic tetralone
Prior art date
Application number
ARP020104076A
Other languages
English (en)
Inventor
Luarent Berger
Raphael Duval
Philippe Taillasson
Ingo Weber
Alexander Wick
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR037046A1 publication Critical patent/AR037046A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicación 1:Un procedimiento para resolver cromatográficamente tetralona quiral sustancial y enantioméricamente pura a partir de una mezcla de dos enantiómeros de tetralona que comprende la provisión de una fase móvil líquida que comprende al menos un solvente; la provisión de una fase quiral estacionaria que comprende un portador inorgánico que tiene un complejo metálico-orgánico ópticamente puro; y, la separación cromatográfica de la mezcla para obtener al menos una tetralona sustancial y enantioméricamente pura.
ARP020104076A 2001-10-31 2002-10-28 Un procedimiento para la preparacion de tetralona racemica opticamente pura o enriquecida AR037046A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33542901P 2001-10-31 2001-10-31

Publications (1)

Publication Number Publication Date
AR037046A1 true AR037046A1 (es) 2004-10-20

Family

ID=23311732

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020104076A AR037046A1 (es) 2001-10-31 2002-10-28 Un procedimiento para la preparacion de tetralona racemica opticamente pura o enriquecida

Country Status (22)

Country Link
US (1) US6683220B2 (es)
EP (1) EP1444188A1 (es)
JP (1) JP2005507935A (es)
KR (1) KR20040070345A (es)
CN (1) CN1578756A (es)
AR (1) AR037046A1 (es)
BR (1) BR0213787A (es)
CA (1) CA2464916A1 (es)
EG (1) EG23132A (es)
HN (1) HN2002000308A (es)
IL (1) IL161256A0 (es)
MX (1) MXPA04003289A (es)
MY (1) MY133291A (es)
PA (1) PA8557601A1 (es)
PL (1) PL369722A1 (es)
RS (1) RS37204A (es)
RU (1) RU2004116325A (es)
SV (1) SV2003001293A (es)
TN (1) TNSN02087A1 (es)
TW (1) TWI221468B (es)
WO (1) WO2003037840A1 (es)
ZA (1) ZA200402652B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05011038A (es) * 2003-04-14 2006-01-24 Teva Pharma Hidrogenacion de compuestos intermedios de imina de sertralina con catalizadores.
US20060128955A1 (en) * 2003-05-09 2006-06-15 Vela Pharmaceuticals, Inc. Method of isolating (R)-tofisopam
KR100739537B1 (ko) * 2004-01-07 2007-07-13 주식회사 카이로라이트 카이랄 무기-유기 혼성 다공성 물질 및 이의 제조 방법
US7345201B2 (en) * 2005-02-23 2008-03-18 Teva Pharmaceutical Industries, Ltd. Processes for preparing sertraline
US7413660B2 (en) * 2005-09-30 2008-08-19 3M Innovative Properties Company Single pass method and apparatus for separating a target molecule from a liquid mixture
KR100925316B1 (ko) * 2007-12-20 2009-11-04 노운섭 접합필름인쇄용 잉크조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639824A (en) * 1991-02-28 1997-06-17 Daicel Chemical Industries, Ltd. Separating agent containing a support and a cyclodextrin derivative
US5403898A (en) * 1992-05-04 1995-04-04 Brigham Young University Single arm attached cyclodextrin polysiloxanes and use thereof as chiral stationary phases in chromatographic separation of enantiomers
DK0724552T3 (da) * 1993-11-30 1997-12-22 Pfizer Fremgangsmåde til fremstilling af chiralt tetralon
WO1999057089A1 (en) * 1998-05-01 1999-11-11 Pfizer Products Inc. Process for the production of enantiomerically pure or optically enriched sertraline-tetralone using continuous chromatography
FR2785196B1 (fr) * 1998-10-29 2000-12-15 Inst Francais Du Petrole Procede et dispositif de separation avec des zones chromatographiques a longueur variable

Also Published As

Publication number Publication date
US20030105364A1 (en) 2003-06-05
SV2003001293A (es) 2003-04-03
US6683220B2 (en) 2004-01-27
TNSN02087A1 (fr) 2004-03-05
EG23132A (en) 2004-04-28
PA8557601A1 (es) 2004-02-07
WO2003037840A1 (en) 2003-05-08
RS37204A (sr) 2006-12-15
BR0213787A (pt) 2004-11-09
MXPA04003289A (es) 2004-07-23
CA2464916A1 (en) 2003-05-08
CN1578756A (zh) 2005-02-09
JP2005507935A (ja) 2005-03-24
WO2003037840A8 (en) 2004-07-22
RU2004116325A (ru) 2005-11-10
EP1444188A1 (en) 2004-08-11
MY133291A (en) 2007-11-30
TWI221468B (en) 2004-10-01
HN2002000308A (es) 2003-01-18
ZA200402652B (en) 2006-05-31
IL161256A0 (en) 2004-09-27
KR20040070345A (ko) 2004-08-07
PL369722A1 (en) 2005-05-02

Similar Documents

Publication Publication Date Title
DK1073618T3 (da) Fremgangsmåde til fremstilling af enantiomerisk ren eller optisk beriget sertralin-tetralon under anvendelse af kontinuerlig kromatografi
BR0210817A (pt) Método para a preparação de escitalopram, e, intermediário
DE60232468D1 (de) Ente und damit zusammenhängende verfahren
DE59409378D1 (de) Verfahren zur Herstellung von 3R,5S-(+)-Natrium-erythro-(E)-7-[4-(4-fluorphenyl)--2,6-diisopropyl-5-methoxymethyl-pyrid-3-yl]-3,5-dihydroxy-hept-6-enoat
DK144694A (da) Fremgangsmåde til fremstilling af en optisk ren enantiomer af formoterol
DK1133283T3 (da) Fremgangsmåde til fremstilling af lægemiddelpartikler
FI954423A0 (fi) Menetelmä taksoidien puhdistamiseksi
CO4940432A1 (es) (+)-norcisapride
AR037046A1 (es) Un procedimiento para la preparacion de tetralona racemica opticamente pura o enriquecida
ES2105510T3 (es) Resolucion enantiomerica de 4-(3,4-diclorofenil)-3,4-dihidro-1(2h)-naftalenona.
Pirkle et al. On the relevance of face-to-edge π-π interactions to chiral recognition
Raja et al. Chiral separation of calcium channel antagonists by SFC and HPLC using different immobilized chiral stationary phases
BRPI0408978B8 (pt) processos para regenerar uma fase estacionária cromatográfica
BR9903274A (pt) Processo para isolar vitamina d3
IL140240A0 (en) Chiral stationary phases for enantiomer separation and their preparation
ATE303361T1 (de) Verfahren zur herstellung von enantiomerenreinem n-methyl- n- (1s)- 1-phenyl- 2-((3s)-3- hydroxypyrrolidin- 1-yl)ethyl)- 2,2- diphenylacetamid
ES2099477T3 (es) Procedimiento para separar enantiomeros a partir de una mezcla racemica.
GB2427374A (en) Compositions and methods for separating enantiomers
Uray et al. Diphenylethanediamine derivatives as chiral selectors: III. Comparison of four new diastereomeric chiral stationary phases prepared by addition of mono-3, 5-dinitrobenzoyldiphenylethanediamine derivatives to optically pure epoxy silica
EP1391239A4 (en) FILLER FOR SEPARATING AN OPTICAL ISOMER, MANUFACTURING METHOD THEREFOR AND APPLICATION METHOD THEREFOR
EA200000069A1 (ru) Способ получения 4-замещенных-1h-индол-3-глиоксамидов
EP1712905A4 (en) METHOD FOR SEPARATING OPTICAL ISOMERS USING SUPERCRITICAL LIQUID CHROMATOGRAPHY
NO994928L (no) FremgangsmÕte ved fremstilling av enkelt-enantiomer narwedine
DK1017666T3 (da) Fremgangsmåde til at forøge den optiske renhed af 2R-[1-hydroxy-1-trifluormethyl-3-cyclopropylpropyn-2-yl]-4-chloranilin
DK0975618T3 (da) Ny fremgangsmåde til fremstilling af 3-N,N-dicyclobutylamino-8-fluor-3,4-dihydro-2H-1-benzopyran-5-carboxamid

Legal Events

Date Code Title Description
FG Grant, registration